Stay updated on E2609 Dose-Finding in Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the E2609 Dose-Finding in Alzheimer's Disease Clinical Trial page.

Latest updates to the E2609 Dose-Finding in Alzheimer's Disease Clinical Trial page
- Check5 days agoChange DetectedThe clinical trial record is displayed with study details, including its terminated status, participant criteria, study design, outcome measures, and linked study documents, replacing the previous error page.SummaryDifference69%

- Check12 days agoChange DetectedThe ClinicalTrials.gov page still displays a 403 Forbidden error. Its footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA site-wide NIH notice about using “Super Intelligence” in place of “Artificial Intelligence” appears, and the site revision advances from v3.7.1 to v3.7.2. The page still displays a 403 error instead of the study record.SummaryDifference1%

- Check40 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check47 days agoChange DetectedThe 403 error text and its HTML were removed from the page, indicating the site is no longer serving the error view and is returning the actual study details content.SummaryDifference0.5%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the expected study record content, indicating the page is currently inaccessible while the site chrome remains visible.SummaryDifference20%

Stay in the know with updates to E2609 Dose-Finding in Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the E2609 Dose-Finding in Alzheimer's Disease Clinical Trial page.